We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Integrated Device Combines Techniques to Detect Malaria

By LabMedica International staff writers
Posted on 08 Dec 2015
Recombinase polymerase amplification (RPA) is promising for further development since it operates in a short time frame and produces a product that can be visually detected on a lateral flow dipstick.

Isothermal amplification techniques are emerging as a promising method for malaria diagnosis since they are capable of detecting extremely low concentrations of parasite target while mitigating the need for infrastructure and training required by other nucleic acid based tests. More...


Bioengineers at Rice University (Houston, TX, USA) developed an integrated device capable of carrying out isothermal amplification using the RPA reaction, post-amplification dilution, and lateral flow detection of the resulting product. The paper and plastic device developed amplified the target using RPA; diluted the resulting product; and detected the product using a lateral flow sandwich assay. In addition, the device transferred the product between the amplification, dilution, and detection modules. A sequence of paper pads loaded with various reagents was used to carry out these functions.

The device is made of simple components, can be assembled by the user and uses a novel slider method to transport reagents through the system. The equipment needed beyond the device itself and the sample to be tested are a hot plate capable of 37 °C, a reusable 25 gram metal weight, the RPA master mix, the running/dilution buffer and pipettes to load these reagents onto the device dilution, running buffer, RPA and sample pads. This device runs the entire assay, including detection, in around an hour and has a limit of detection equivalent to when the assay is run using conventional methods on the bench top. The total run time for the device is 55 minutes, and including the loading and operation of the device, the entire assay can be carried out in about an hour.

The authors concluded that the fabricated device amplified a sequence which is common to the human infectious species of Plasmodium and operated an isothermal amplification reaction which is rapid and has an easy visual readout. A paper and plastic device was also developed which carries out the amplification of the samples, dilutes the product and runs the result on a lateral flow strip. When tested on synthetic targets, a limit of detection of 5 copies/µL (50 total copies) was found, which matches the performance of the same assay run on the bench top. The study was published on November 26, 2015, in the Malaria Journal.

Related Links:

Rice University 



Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Herpes Simplex Virus ELISA
HSV 2 IgG – ELISA
New
Alpha-Fetoprotein Reagent
AFP Reagent Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: Schematic diagram of multimodal single-cell MSI using tapping-mode scanning probe electrospray ionization (Photo courtesy of Yoichi Otsuka)

New Technology Improves Understanding of Complex Biological Samples

Tissues are composed of a complex mixture of various cell types, which complicates our understanding of their biological roles and the study of diseases. Now, a multi-institutional team of researchers... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.